This episode is sponsored by AGNTCY. Unlock agents at scale with an open Internet of Agents. Visit https://agntcy.org/ and add your support. Can AI and RNA testing make illness optional? In this episode, Eye on AI host Craig S. Smith sits down with Naveen Jain, founder and CEO of Viome, to explore how RNA sequencing and artificial intelligence are transforming our understanding of chronic disease. Jain shares how a personal tragedy led him to launch Viome, a company on a mission to digitize the human body, predict illness before symptoms appear, and revolutionize healthcare. Together they discuss how Viome uses metatranscriptomics to analyze microbiome and human gene expression, what makes RNA a better indicator of health than DNA, and how large molecular AI models are paving the way for early detection of cancer, diabetes, Alzheimer's, and more. Jain also reveals his bold entrepreneurial framework—"Why this, why now, why me?"—and his belief that asking better questions is the real key to innovation. If you're interested in the intersection of AI, biotechnology, and human longevity, this is an episode you won't want to miss. Stay Updated: Craig Smith on X:https://x.com/craigss Eye on A.I. on X: https://x.com/EyeOn_AI